Announcement on Implementation Results of Share Repurchase
Filed with SSE · · 3 pages · Chinese
Beijing Balance Medical Technology Co. Ltd. on 6ix
Earlier from Beijing Balance Medical Technology
- Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease
- Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices
- Announcement on Voluntary Disclosure of the Failure to Obtain Approval for the Registration Application for Ophthalmic Surgical Biological Patch
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Later from Beijing Balance Medical Technology
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Vesting Results for the 4th Vesting Period of the Reserved Grant under the 2020 Restricted Share Incentive Plan and Listing of Shares
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of Entry of ePTFE Pulmonary Artery Valved Conduit into the Special Review Procedure for Innovative Medical Devices
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure Regarding the Entry of the Minimally Invasive Pre-positionable Sutureless Aortic Valve System into the Special Review Procedure for Innovative Medical Devices
Follow Beijing Balance Medical Technology into a list and get an email when it puts out news.
Follow Beijing Balance Medical Technology